Genetically Modified Chickens That Overexpress Defensin Peptides Resist Salmonella and Other Pathogens | Research

The takeaway

Chickens engineered to overexpress antimicrobial peptides — ovotransferrin and avian β-defensin-3 — produced eggs and meat with significantly reduced bacterial contamination, including Salmonella.

Significant reduction
in Salmonella enterica growth in egg whites from transgenic chickens overexpressing antimicrobial peptides

What the researchers found

Transgenic chickens overexpressing ovotransferrin or avian β-defensin-3 (AvβD3) showed antimicrobial peptide expression in egg white, breast muscle, and serum at both RNA and protein levels.

The antimicrobial effects were substantial: transgene expression significantly reduced growth of aerobic bacteria and coliforms in breast muscle, and decreased Salmonella enterica growth in egg white. The peptides inhibited growth of both human and chicken bacterial pathogens as well as spoilage bacteria in vitro.

Beyond the direct antimicrobial effects, the transgenic birds also showed changes to their immune systems, including increased proportions of CD8+ T cells in blood — suggesting the overexpressed peptides also boosted innate immunity.

Why it matters

Foodborne illness from poultry products — especially Salmonella — sickens millions of people annually. This study demonstrates a fundamentally different approach: rather than treating contamination after the fact, antimicrobial peptides are produced by the chickens themselves, reducing pathogens in meat and eggs from the start. It also shows defensins can modulate the birds' immune systems, providing a dual benefit.

How the study worked

Researchers used Tol-2 transposon technology to genetically modify chickens to overexpress either ovotransferrin or avian β-defensin-3. They confirmed transgene expression at the RNA and protein level across multiple tissues. Antimicrobial activity was tested in vitro against various bacterial pathogens. Immune cell populations in blood, bursa, and spleen were analyzed by flow cytometry.

What this study cannot tell us

This study used genetically modified chickens, which face significant regulatory and public acceptance barriers in most countries. The antimicrobial testing was primarily done in vitro, and real-world food production conditions may differ. Long-term effects of peptide overexpression on chicken health, welfare, and production performance were not fully characterized. Whether bacteria could develop resistance to these overexpressed peptides over time was not addressed.

How to read the evidence

This is a preclinical animal study using genetically modified chickens with primarily in vitro antimicrobial testing. It provides proof-of-concept evidence but is far from clinical application for human food safety.

When this study was published

Published in 2019, this study represents relatively recent work in agricultural peptide biotechnology. The technology has not yet been approved for commercial poultry production in any country.

The bigger picture

This research sits at the intersection of antimicrobial peptide biology and agricultural biotechnology. Defensins are a major class of innate immune peptides found across all vertebrates, and understanding how overexpression affects both direct pathogen killing and immune modulation has implications beyond poultry. It demonstrates the real-world applicability of antimicrobial peptides in food safety, a growing concern as antibiotic resistance makes traditional approaches less effective.

Questions still open

Could similar antimicrobial peptide overexpression approaches work in other livestock species to reduce foodborne illness?
Would prolonged exposure to overexpressed defensins in poultry products drive bacterial resistance?
Could non-transgenic methods (like feed additives containing defensin peptides) achieve similar food safety benefits?

Common questions

What are avian β-defensins and ovotransferrin?

Avian β-defensin-3 is a small antimicrobial peptide that chickens naturally produce as part of their innate immune system — it kills bacteria by disrupting their cell membranes. Ovotransferrin is an iron-binding protein found in egg whites that starves bacteria of the iron they need to grow. Both are natural defense molecules that the researchers boosted through genetic engineering.

Could this technology make poultry products safer for humans?

In theory, yes — the transgenic chickens' products had significantly less bacterial contamination, including reduced Salmonella. However, genetically modified animals face major regulatory hurdles and public skepticism in most countries. The technology would need extensive safety testing and regulatory approval before reaching consumers.

Read the original research

Overexpressing ovotransferrin and avian β-defensin-3 improves antimicrobial capacity of chickens and poultry products.

Transgenic research, 28(1), 51-76

View on PubMed ↗Publisher’s paper ↗

Citation

Cooper, Caitlin A; Tizard, Mark L; Stanborough, Tamsyn; Moore, Sean C; Chandry, P Scott; Jenkins, Kristie A; Wise, Terry G; O'Neil, Terri E; Layton, Daniel S; Morris, Kirsten R; Moore, Robert J; Fegan, Narelle; Doran, Timothy J. (2019). Overexpressing ovotransferrin and avian β-defensin-3 improves antimicrobial capacity of chickens and poultry products.. Transgenic research, 28(1), 51-76. https://doi.org/10.1007/s11248-018-0101-2